No Data
No Data
Express News | Ocean Biomedical- Ownership in Virion to Equal 22% of Virion's Issued & Outstanding Membership Interests, in Exchange for $9 Mln
Express News | Ocean Biomedical- Ratified Fully Countersigned Copy of Revised Agreement With Virion Therapeutics Received on Sept 26
Ocean Biomedical, Molecure Sign Licensing Agreement for YKL-40 Inhibitors
Molecure (WSE: MOC) and Nasdaq-listed Biotechnology Company Ocean Biomedical (NASDAQ: OCEA) Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 Inhibitors.
Ocean Biomedical's Oncology Platform Included in New Published Study
Ocean Biomedical Announces Publication Of New Data Deepening Understanding Of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 And Its Ability To Inhibit Anti-Tumor And Related Tissue Remodeling Responses
No Data
No Data